Muscle Relaxant Recalled

Dr Reddy’s Laboratories Inc is recalling 37,560 bottles of tizanidine because of shaved tablets, according to the August 25, 2021, US Food and Drug Administration (FDA) Enforcement Report.

The recall affects tizanidine hydrochloride tablets, 4 mg, 150-count bottles (NDC 55111-180-15), from lot T2000471 (Exp. 9/23). The tablets were manufactured by Dr. Reddy's Laboratories, Srikakulam district, India, and distributed in the United States.

Dr. Reddy’s Laboratories initiated the recall July 19, 2021. The FDA designated the recall Class II on August 18, 2021. Drugs affected by Class II recalls may cause temporary or medically reversible adverse health consequences if used. While remote, a possibility of serious harm also exists.

Tizanidine is a prescription medication used to muscle spasms.